Targeting tumor vasculature: Reality or a dream?

Journal of Drug Targeting

Volumn 10, Issue 7, 2002, Pages 529-533

  Satchi Fainaro, Ronit ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 DIMETHYL 5 (2 OXO 1H INDOL 3 YLMETHYLENE) 3 PYRROLEPROPIONIC ACID; 4 DEDIMETHYLAMINOSANCYCLINE; ADENOVIRUS VECTOR; AE 941; ALPHA INTERFERON; ANGIOGENESIS INHIBITOR; ANGIOSTATIN; ANTINEOPLASTIC AGENT; CETUXIMAB; CILENGITIDE; COLCHICINE DERIVATIVE; COMBRETASTATIN; ENDOSTATIN; FIBROBLAST GROWTH FACTOR; FUMAGILLOL CHLOROACETYLCARBAMATE; IM 862; INTERLEUKIN 12; MARIMASTAT; MARISTAT; MITOFLAXONE; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY LM 609; POLYMER; PRINOMASTAT; SQUALAMINE; THALIDOMIDE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VASCULOTROPIN; VASCULOTROPIN ANTIBODY; VASCULOTROPIN INHIBITOR; VASCULOTROPIN RECEPTOR 3; VATALANIB;

ANTINEOPLASTIC ACTIVITY; CARCINOGENESIS; CLINICAL TRIAL; DOSE RESPONSE; DRUG BIOAVAILABILITY; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG MECHANISM; DRUG RELEASE; DRUG TARGETING; DRUG TISSUE LEVEL; HUMAN; METASTASIS; PRIORITY JOURNAL; SHORT SURVEY; SIDE EFFECT; TUMOR GROWTH; TUMOR VASCULARIZATION; VIRAL GENE DELIVERY SYSTEM;

ANGIOGENESIS INHIBITORS; ANIMALS; ENDOTHELIUM, VASCULAR; HUMANS; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; REGIONAL BLOOD FLOW;

EID: 0036875489     PISSN: 1061186X     EISSN: None     Source Type: Journal    
DOI: 10.1080/1061186021000051062     Document Type: Short Survey

References (34)

1. Arap, W., Kolonin, M.G., Trepel, M., Lahdenranta, J., Cardo-Vila, M., Giordano, R.J., Mintz, P.J., Ardelt, P.U., Yao, V.J., Vidal, C.I., Chen, L., Flamm, A., Valtanen, H., Weavind, L.M., Hicks, M.E., Pollock, R.E., Botz, G.H., Bucana, C.D., Koivunen, E., Cahill, D., Troncoso, P., Baggerly, K.A., Pentz, R.D., Do, K.A., Logothetis, C.J. and Pasqualini, R. (2002) "Steps toward mapping the human vasculature by phage display", Nat. Med. 8, 121-127.
2. Bloom, V.N., Shaish, A., Gonen, A., Levanon, K., Greenberger, S., Ferber, S., Levkovitz, H., Castel, D., Goldberg, I., Afek, A., Kopolovitc, Y. and Harats, D. (2001) "Tissue-specific gene therapy directed to tumor angiogenesis", Gene Ther. 8(11), 819-827.
3. Brocchini, S. and Duncan, R. (1999) "Pendent drugs, release from polymers", In: Mathiowitz, E., ed, Encyclopedia of Controlled Drug Delivery (Wiley, New York), pp. 786-816.
4. Browder, T., Butterfield, C.E., Kräling, B.M., Shi, B., Marshall, B., O'Reilly, M.S. and Folkman, J. (2000) "Antiangiogenic scheduling of chemotherapy improves efficacy against experimental drug-resistant cancer", Cancer Res. 60, 1878-1886.
5. Carmeliet, P. and Jain, R.K. (2000) "Angiogenesis in cancer and other diseases", Nature 407, 249-257.
6. Duncan, R., Gac-Breton, S., Keane, R., Musila, R., Sat, Y.N., Satchi, R. and Searle, F. (2001) "Polymer-drug conjugates, PDEPT and PELT: basic principles for design and transfer from the laboratory to clinic", J. Control. Release 74(1-3), 135-146.
7. Eliceiri, B.P. and Cheresh, D.A. (2001) "Adhesion events in angiogenesis", Curr Opin. Cell Biol. 13, 563-568.
8. Folkman, J. (1971) "Tumor angiogenesis: therapeutic implications", N. Engl. J. Med. 285, 1182-1186.
9. Folkman, J. (1999) "Angiogenic zip code", Nat. Biotechnol. 17, 749.
10. Folkman, J. (2001a) "Angiogenesis-dependent diseases", Semin. Oncol. 28, 536-542.
11. Folkman, J. (2001b) "Angiogenesis", In: Braunwald, E., Fauci, A.S., Kasper, D.L., Hauser, S.L., Longo, D.L. and Jameson, J.L., eds, Harrison's Textbook of Internal Medicine, 15th Ed. (McGraw-Hill, New York), pp. 517-530.
12. Gabizon, A.A. (2001) "Pegylated liposomal doxorubicin: metamorphosis of an old drug into a new form of chemotherapy", Cancer Investig. 19, 424-436.
13. Gabizon, A. and Martin, F. (1997) "Polyethylene glycol-coated (pegylated) liposomal doxorubicin. Rationale for use in solid tumours", Drugs 54(Suppl. 4), 15-21.
14. Gregoriadis, G. (1995) "Engineering liposomes for drug delivery: progress and problems", Trends Biotechnol. 13, 527-537.
15. Gyorffy, S., Palmer, K. and Gauldie, J. (2001) "Adenoviral vector expressing murine angiostatin inhibits a model of breast cancer metastatic growth in the lungs of mice", Am. J. Pathol. 159(3), 1137-1147.
16. Hanahan, D. and Folkman, J. (1996) "Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis", Cell 86, 353-364.
17. Hill, S.A., Tozer, G.M., Petit, G.R. and Chaplin, D.J. (2002) "Preclinical evaluation of the antitumour activity of the novel vascular targeting agent Oxi 4503", Anticancer Res. 22(3), 1453-1458.
18. Hood, J.D., Bednarski, M., Frausto, R., Guccione, S., Reisfeld, R.A., Xiang, R. and Cheresh, D.A. (2002) "Tumor regression by targeted gene delivery to the neovasculature", Science 296(5577), 2404-2407.
19. Ingber, D., Fujita, T., Kishimoto, S., Sudo, K., Kanamaru, T., Brem, H. and Folkman, J. (1990) "Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth", Nature 348, 555-557.
20. Jain, R.K. (1998) "Delivery of molecular and cellular medicine to solid tumors", J. Control. Release 53, 49-67.
21. Koivunen, E., Arap, W., Valtanen, H., Rainisalo, A., Medina, O.P., Heikkila, P., Kantor, C., Gahmberg, C.G., Salo, T., Konttinen, Y.T., Sorsa, T., Ruoslahti, E. and Pasqualini, R. (1999) "Tumor targeting with a selective gelatinase inhibitor", Nat. Biotechnol. 17, 768-774.
22. Kuo, C.J., Farnebo, F., Yu, E.Y., Christofferson, R., Swearingen, R.A., Carter, R., von Recum, H.A., Yuan, J., Kamihara, J., Flynn, E., D'Amato, R., Folkman, J. and Mulligan, R.C. (2001) "Comparative evaluation of the antitumor activity of antiangiogenic proteins delivered by gene transfer", Proc. Natl Acad. Sci. USA 98(8), 4605-4610.
23. Lyden, D., Hattori, K., Dias, S., Costa, C., Blaikie, P., Burros, L., Chadburn, A., Heissig, B., Marks, W., Witte, L., Wu, Y., Hicklin, D., Zhu, Z., Hackett, N.R., Crystal, R.G., Moore, M.A,, Hajjar, K.A., Manova, K., Benezra, R. and Rafii, S. (2001) "Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth", Nat. Med. 7, 1194-1201.
24. Maeda, H., Wu, J., Sawa, T., Matsumura, Y. and Hori, K. (2000) "Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review", J Control. Release 65, 271-284.
25. Maeshima, Y., Sudhakar, A., Lively, J.C., Ueki, K., Kharbanda, S., Kahn, C.R., Sonenberg, N., Hynes, R.O. and Kalluri, R. (2002) "Tumstatin an endothelial cell-specific inhibitor of protein synthesis", Science 295, 140-143.
26. Papahadjopoulos, D., Allen, T.M., Gabizon, A., Mayhew, E., Matthay, K., Huang, S.K., Lee, K.D., Woodle, M.C., Lasic, D.D., Redemann, C., et al. (1991) "Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy", Proc. Natl Acad. Sci. USA 88, 11460-11464.
27. Pasqualini, R., Koivunen, E. and Ruoslahti, E. (1997) "Alpha v integrins as receptors for tumor targeting by circulating ligands", Nat. Biotechnol. 15, 542-546.
28. Satchi-Fainaro, R., Mamluk, R., Puder, M., Greene, A.K., Soker, S. and Folkman, J. (2002) Polymer therapeutics of angiogenesis inhibitors: HPMA copolymer-TNP-470 conjugate, Proc. 29th Int'l. Symp. Controlled Rel. Bioact. Materials, Seoul, Korea.
29. Sauter, B.V., Martinet, O., Zhang, W.J., Mandeli, J. and Woo, S.L. (2000) "Adenovirus-mediated gene transfer of endostatin in vivo results in high level of transgene expression and inhibition of tumor growth and metastases", Proc. Natl Acad. Sci. USA 97(9), 4802-4807.
30. Savontaus, M.J., Sauter, B.V., Huang, T.G. and Woo, S.L. (2002) "Transcriptional targeting of conditionally replicating adenovirus to dividing endothelial cells", Gene Ther 9, 972-979.
31. St. Croix, B., Rago, C., Velculescu, V., Traverso, G., Romans, K.E., Mongomery, E., Lal, A., Riggins, G.J., Lengauer, C., Vogelstein, B. and Kinzler, K.W. (2000) "Genes expressed in human tumor endothelium", Science 289, 1197-1202.
32. Symon, Z., Peyser, A., Tzemach, D., Lyass, O., Sucher, E., Shezen, E. and Gabizon, A. (1999) "Selective delivery of doxorubicin to patients with breast carcinoma metastases by stealth liposomes", Cancer 86, 72-78.
33. Yancopoulos, G.D., Klagsburn, M. and Folkman, J. (1998) "Vasculogenesis, angiogenesis, and growth factors: ephrins enter the fray at the border", Cell 93, 661-664.
34. Yu, J.L., Rak, J.W., Coomber, B.L., Hicklin, D.J. and Kerbel, R.S. (2002) "Effect of p53 status on tumor response to antiangiogenic therapy", Science 295, 1526-1528.